Evaluating Repligen (RGEN) After Sharp Share Price Declines and Conflicting Valuation Signals [Yahoo! Finance]
Repligen Corporation (RGEN)
Last repligen corporation earnings: 2/20 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
repligen.com/investors
Company Research
Source: Yahoo! Finance
If you are wondering whether Repligen at around US$119.99 is a bargain or still looks expensive, you are not alone. That is exactly what this article aims to unpack for you. Over the past week the stock has seen a 6.8% decline, extending to a 15.6% decline over 30 days and a 27.0% decline year to date, with a 22.9% decline over 1 year and a 27.8% decline over 3 years that compares with a 38.4% decline over 5 years. Recent coverage around Repligen has focused on its role in bioprocessing tools and services. This anchors expectations about how investors think about its long term demand and competitive position. This context helps explain why the share price can react strongly when sentiment around the broader biopharma tools space shifts, even without company specific announcements. On our framework Repligen has a valuation score of 3 out of 6 . Next we will look at how different valuation approaches arrive at that view, before finishing with a way to assess value that brings all
Show less
Read more
Impact Snapshot
Event Time:
RGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGEN alerts
High impacting Repligen Corporation news events
Weekly update
A roundup of the hottest topics
RGEN
News
- 2 Growth Stocks Set to Flourishand 1 We Turn Down [Yahoo! Finance]Yahoo! Finance
- Repligen Corporation (RGEN) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]Seeking Alpha
- Reassessing Repligen (RGEN) Valuation After Sector Pullback And Profitability Concerns [Yahoo! Finance]Yahoo! Finance
- Repligen Corporation to Present at Upcoming March Conferences [Yahoo! Finance]Yahoo! Finance
- Repligen Corporation to Present at Upcoming March ConferencesGlobeNewswire
RGEN
Earnings
- 2/24/26 - Beat
RGEN
Sec Filings
- 3/5/26 - Form 4
- 3/5/26 - Form 4
- 3/3/26 - Form 4
- RGEN's page on the SEC website